Blood Testing Technology Market Report Profiling Major Players: Abbott Laboratories, F. Hoffmann-La Roche AG, Beckman Coulter Inc, Siemens AG., Thermo Fisher Scientific Inc, Becton Dickinson and Company & Many Others

Testing of blood is one of the oldest and most widely used techniques to rule out the presence of any disease. Blood tests are used to assure the biochemical and physiological well-being of the humans. They are also used to confirm the proper functioning of vital organs such as liver, kidney and thyroid and to understand the effectiveness of given therapeutics. The technological innovations along with consistent demand for better blood testing technologies have intensified the global competition. The market is growing owing to the burgeoning demand for point-of-care and minimally invasive testing devices.

Download Report and TOC Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/659

The major factors fuelling the global blood testing technologies market growth are high incidence of lifestyle diseases, cancer, infectious diseases and genetic disorders. Large pool of old age population along with increased public and private spending on diagnostics and research are other significant factors leading to market growth. Rising number of diagnostic centers, hospitals and emergence of home care diagnostics have opened lucrative avenues in the blood testing market. However, lack of awareness, reluctance to adopt newer technologies and unavailability of skilled labor are likely to restrain the market growth.

The global blood testing technologies market is segmented on the basis of type, technology, end user and geography. On the basis of type, the market is segmented into Complete Blood Count (CBC), Basic Metabolic Panel (BMP) such as blood glucose test, electrolyte test and kidney test; blood enzyme tests such as Troponin and Creatine Kinase; tests to assess heart disease risk such as lipoprotein panel and cholesterol test and blood clotting tests; and others such as Erythrocyte Sedimentation Rate (ESR). On the basis of technology, the market is segmented into Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescent immunoassay (CLIA), Radioimmunoprecipitation assay (RIPA), Nucleic Acid Amplification Test (NAAT), Polymerase Chain Reaction (PCR), Transcription-mediated Amplification (TMA), Enzyme Immunoassay (EIA), Immunofluorescence Assay (IFA), Next Generation Sequencing (NGS) and Western Blot Test. The market is segmented on the basis of end user into hospitals and clinics, diagnostic centers and homes. Geographically, the market is segmented across four regions viz., North America, Europe, Asia-Pacific and LAMEA.

Few strategies adopted by industrial players are collaborations and acquisitions. For instance Roche Diagnostics, in Dec 2014, acquired Ariosa Diagnostics, to enter into non-invasive prenatal test (NIPT) and cell-free DNA testing services markets. Ariosa’s proprietary Harmony Prenatal Test is a blood test that measures fetal cfDNA found in maternal blood. Recently, Philips has entered into collaboration agreement with Janssen Pharmaceutica N.V., to develop a handheld blood test intended to be used in neuropsychiatric care.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/659

The companies profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Siemens AG., Thermo Fisher Scientific Inc., Becton Dickinson and Company, bioMérieux SA, Koninklijke Philips N.V., Alere Inc. and Medtronic plc.

KEY MARKET BENEFITS

• Comprehensive analysis of factors that drive and restrict the growth of the global blood testing technologies market is provided
• The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
• An in-depth analysis of key segments of the market demonstrates the types of blood testing equipment along with the technologies and end-users in blood testing market
• SWOT analysis enables to study the internal environment of the leading companies for strategy formulation
Region-wise blood testing technologies market conditions are comprehensively analyzed in this report

Table Of Content

Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Access Full Summery @ https://www.alliedmarketresearch.com/blood-testing-technologies-market

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.